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Abstract Biotransformation of diethyl 1-hydroxy-1-phe-
nylmethanephosphonate using fungi Beauveria bassiana
allowed resolving the racemic mixture of the substrate and
due to the biocatalyst and reaction conditions modiﬁca-
tions, leading to desired optical isomer.
Introduction
‘‘Efﬁciency’’ and ‘‘selectivity’’ are two key words that
better outline the outstanding of biocatalysts performance.
Chirality is, in the most cases, the most important factor in
the safety and efﬁcacy of many drug products [1]. Usually,
only one enantiomer is responsible for the desired activity,
whereas its counterpart can be inactive, be an antagonist of
the active one or posses other desirable activity or is no
active at all. Biocatalysts are applied usually, when
chemical synthesis fails either when products of desired
chirality are required or because of the environmental
purposes [9, 14, 18, 20]. Microbial biocatalysts demon-
strated wide variations of activities, though it justiﬁed
dynamic development of the biotransformation ﬁeld of
science [7, 13]. Phosphonates are compounds containing
direct P–C bond. Among them are molecules with one or
two stereogenic centers, their biological activities range
from the medicine to agriculture and strongly dependent on
their absolute conﬁguration. They affect the amino acids
metabolism inﬂuencing the activity of the enzymes
involved in it via structural analogy to the particular car-
boxylic acids or by the transition state imitation (during the
enzymatic peptide bond hydrolysis) [2, 4–6, 12]. They act
as antibacterials, antivirals, neuromodulators, chelating
agents in bone diseases or herbicides, and also they can
serve as chiral building blocks in combinatorial chemistry
[2, 4–6, 12]. Biocatalyzed synthesis of chiral, organo-
phosphorus compounds is still not fully explored, although
during last decade puriﬁed enzymes and whole microbial
cells were successfully used for the synthesis of structurally
different, optically pure phosphonate derivatives [3, 8, 10,
11, 15, 19, 21, 22, 24]. Here, we report effective and
simple strategy, which allowed obtaining non-racemic,
diethyl 1-hydroxy-1-phenylmethanephosphonate in both
optical forms, with the yield of 20% (resolution of the
racemic mixtures is under kinetic control) (Fig. 1). This
compound represents a structure of possible application as
a chiral building block or chelating agent and as a potential
enzyme inhibitor.
Materials and Methods
Substrate Synthesis
Substrate was synthesized according to the standard pro-
cedure by the addition of equimolar ratio of diet-
hylphosphite and KF to benzaldehyde at the presence of
catalytic amount of anhydrous Al2O3 (stirring, room tem-
perature, 24 h) [17].
Microorganism Cultivation
Beauveria bassiana strain (DSM 875) was purchased from
German Collection of Microorganisms and Cell Cultures.
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temperature) on the standard (DSMZ Medium 90) malt
extract peptone liquid medium (100 ml) in 250 ml culti-
vation ﬂask, until the mid-log growth phase (for 3 days),
then the biomass was separated by centrifugation
(4,000 rpm/10 min)—it allowed obtaining 8 g of the wet
cells from every cultivation ﬂask. After that, depending on
the down stream, cells were used directly or preincubated
for next 24 h under starvation conditions and then used as a
biocatalyst. In both cases (with or without the starvation),
also depending on the outcome, the cells were shaken with
the addition of catalytic amount of cyclohexanone (the ﬁnal
concentration of the additive in the biotransformation ﬂask
was 1 mM). Details of the procedures are listed below.
Biotransformation Media
Aqueous medium or citrate buffer (pH 3, 0.05 M)
Biotransformation: General Procedure
Biotransformation (50 mM of the substrate, 8 g wet cells
aftercultivationandcentrifugation)wascarriedoutin50 ml
ofbiotransformationmediaforvarioustimesandatdifferent
temperatures with shaking at 250 rpm. Details of the pro-
tocols are listed below. Biocatalyst cells were removed by
centrifugation (4,000 rpm, 10 min), product was extracted
from the supernatant with ethyl acetate, dried organic layer
was evaporated, and ﬁnal product was analyzed.
Protocol 1 fresh wet biomass, buffer, or aqueous
medium, duration 1–7 days, temp. 22C
Protocol 2 24 h starved biocatalyst cells, buffer, or
aqueous medium, duration 1–7 days, temp.
22C
Protocol 3 24 h starved biocatalyst cells, buffer, or
aqueous medium, duration 1–7 days temp.
30C
Protocol 4 fresh wet biomass, buffer, or aqueous
medium, simultaneous addition of substrate
and cyclohexanone (1 mM), duration 3 days,
temp. 22C
Protocol 5 fresh wet biomass, buffer, or aqueous
medium, cyclohexanone (1 mM) added 24 h
before substrate, duration 1–5 days, temp.
22C
Protocol 6 24 h starved biocatalyst cells, buffer, or
aqueous medium, simultaneous addition of
substrate and cyclohexanone (1 mM),
duration 3 days, temp. 22C
Protocol 7 24 h starved biocatalyst cells, buffer, or
aqueous medium, cyclohexanone (1 mM)
added 24 h before substrate, duration: 2 and
5 days, temp. 22C
NMR Assignments
NMR spectra were recorded on Bruker Avance DRX300
instrument operating at 300.13 MHz, measurements were
made in CDCl3 (99.5 at.% D) at temperature of 300 K.
Purity of the Product, Yield, and Enantiomeric Excess
Determination: Optical Rotation Measurement
Product purity and the enantiomeric excess evaluation were
done using NMR;
31P spectra were recorded with the
addition of equimolar amount of quinine, used as a chiral
discriminator in the case of enantiomeric excess calcula-
tion. Absolute conﬁguration was assayed by optical rota-
tion measurement (in CHCl3), after the biotransformation,
and the results were as follows: in the case of (A)—Fig. 2,
[a]D
20 =- 38 for S enantiomer [16]; in the case (B)—
Fig. 2,[ a]D
20 =? 38 and for R enantiomer.
Results and Discussion
This work was inspired by our previous studies [3, 23],
which employed different strains of fungi for the synthesis
of P-chiral hydroxyphosphonate via enantioselective oxi-
dation of hydroxyl functionality. Chemical procedures of
the synthesis as well as prochiral keto phosphonates and
racemic hydroxylphosphonates are cheap and efﬁcient,
therefore, these compounds can serve as convenient sub-
strates for further reactions, including the biocatalyzed
synthesis of the chiral products in a manner as simple and
as economic as possible. Thus, in discussed case, the fungal
strain Beauveria bassiana was used for the oxidative res-
olution of the racemic mixture of the model—diethyl
1-hydroxy-1-phenylmethanephosphonate. It turned out that
PO3Et2
OH
biocatalyst
PO3Et2
OH
PO3Et2
O
S or R enantiomer
        ketophosphonate,
unstable in aqueous media
Fig. 1 Biocatalyzed synthesis of chiral diethyl 1-hydroxy-1-
phenylmethanephosphonate
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123this biocatalyst was active toward tested compound and,
what is also important, the modiﬁcation as well as the cells
preincubation methods and biotransformation conditions,
implied in the different stereoselectivity of the biooxida-
tion. In order to obtain product of desired absolute con-
ﬁguration, different strategies were applied. First of all, the
biocatalytic biomass was prepared with or without the
starvation period followed the routine cells cultivation. It is
obvious that the phosphonates are not physiological sub-
strates for fungi, that is why, in some cases the starvation
period is the solution, which forces the cells to utilize such
compounds. It is necessary to stress that in discussed
studies, the activity of Beauveria bassiana strain toward
diethyl 1-hydroxy-1-phenylmethanephosphonate, was
similar, no matter if the cells starved or not. However, there
was other factor, signiﬁcantly inﬂuencing the effectiveness
and direction of the biotransformation. Thus, the addition
of the catalytic amount of cyclohexanone (details are
described in the ‘‘Materials and Methods’’ section) allowed
controlling the enantioselectivity of the process, this cru-
cial observation is clearly seen on the NMR spectra, which
show the best results (Fig. 2a, b). The application of this
additive implied in the enriching of the racemic mixture of
the substrate in the enantiomer of R absolute conﬁguration
after one day of biocatalysis. Bioconversion was carried
out in aqueous media, at 22C (Fig. 2b), while the
experiment without any cells preincubation (Fig. 2a)
allowed to increase the amount of the S isomer after the
bioconversion. The e.e values (about 20%) are not satis-
factory, but the procedure is worth to develop, because of
their simplicity and possibility to obtain both the enantio-
meric forms of the substrate.
The possible explanation of this phenomenon is that
cyclohexanone and the biotransformation substrate–
hydroxyphosphonate constitute the oxidases cofactor
regeneration system. The catalytic amount of the additive
moved the balance between the oxidized and reduced
coenzyme forms, into oxidized ones, which were subse-
quently converted into reduced forms, accepting the elec-
trons and protons from the biocatalysis substrate, which
was simultaneously oxidized, what ﬁnally completed the
reaction (Fig. 3).
Except from the mentioned above, variable cells prein-
cubation procedures, Table 1 shows other efforts, which
were undertaken to improve the effectiveness of the chiral
hydroxyphosphonate synthesis. Thus, following conditions
of the biooxidation were changed: temperature 22 or 30C;
the reaction time, which varied from 1 to 7 days; bio-
transformation media—water or citrate buffer were
applied. Unfortunately, these approaches were not effec-
tive, considering the yield and the enantiomeric excess of
the products. However, in Table 1, there are some data,
which undoubtedly focused the attention and required
comments. Thus, the results of the biotransformation car-
ried without the addition of the cyclohexanone are inter-
esting, because the values of the enantiomeric excess
changing with time and in some cases the inversion of the
absolute conﬁguration are observed. The possible expla-
nation of this phenomenon is that enzymes inside the living
cells are constitutive or inducible ones, and depending on
the environmental conditions and on the metabolic state of
the cells, particular enzymes are expressed. It implies in
that the molar ratio of the enzymes of opposite enantio-
speciﬁcities change with the reaction progress. Moreover,
the protein heterogeneity (e.g. enantiospeciﬁcity) often
Fig. 2
31P NMR spectra of biotransformation products recorded with
quinine. a without any additives, predominant enantiomer deﬁned as
S isomer, b cyclohexanone as an additive, predominant enantiomer
deﬁned as R one
cyclohexanone
cyclohexanol
hydroxy-
-phosphonate
keto
phosphonate
reduction
oxidation
NAD+
FAD
NADH
FADH2
Fig. 3 Created cofactor regeneration system—cyclohexanone
importance
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forms of the monomeric enzyme, which also can be an
explanation of the presented in Table 1 data. The results of
the bioconversion are interesting as well, when the reaction
is carried out at the cyclohexanone presence. It is clearly
seen that the added compound affects the activity of the
enzymes involved in the oxidation of the phosphonic
substrate. After the simultaneous introduction of the men-
tioned chemicals, the lack of the reaction is observed or the
results are very poor, it seems that these compounds are
competitive to each other and the cyclohexanone is pre-
ferred one. In turn of the sequence addition (substrate
followed the cyclohexanone), the enantiospeciﬁcity differs
depending also on the biotransformation media. Thus in
water, at early stage of the process, the oxidase of the
S preference is active, so the predominant, unreacted
product is of R absolute conﬁguration. This reaction state is
changing with the bioconversion progress, the enzyme of
opposite speciﬁcity becomes a prevalent one. This phe-
nomenon probably resulted from the reasons already dis-
cussed above. Otherwise, when the biocatalysis is carried
out in buffer the lack of the reaction is observed or the
enzyme of R enantiospeciﬁcity is in the ascendance (pre-
dominant product is of S absolute conﬁguration). It seems
that this results imply largely from the sensitivity of the
oxygenase of opposite speciﬁcity to the presence of the
cations or/and anions, which formed the citric buffer.
Assuming, presented studies are another valuable report of
scope and limitations of the application of the biocatalysts.
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